 WALTHAM, Mass., Nov. 12, 2021 GLOBE NEWSWIRE -- Repligen Corporation NASDAQ:RGEN, a life sciences company focused on bioprocessing technology leadership, today announced that it will present at two upcoming investor conferences. 